Evidence map›Paper›PMID 23443662›Full record

ArticleThe Journal of biological chemistry2013

Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.

Marguerite S Buzza, Erik W Martin, Kathryn H Driesbaugh, Antoine Désilets, Richard Leduc, Toni M Antalis

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Marguerite S BuzzaCenter for Vascular and Inflammatory Diseases and Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
Erik W Martin
Kathryn H Driesbaugh
Antoine Désilets
Richard Leduc
Toni M Antalis
University of Maryland, Baltimore · USUniversité de Sherbrooke · CA

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI FEYRUZ VIRGILIA RASSOOL · 2008 to 2026
$51.0M
Membrane Serine Protease Activities in Protease Activated Receptor SignalingR01HL118390 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2014 to 2017
$1.5M
New Function for the Serpin PAI-2 as a Regulator of pRbR01CA098369 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M. · 2003 to 2007
$1.5M
Vascular Remodeling by Membrane Serine ProteasesR01HL084387 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2007 to 2010
$1.5M
Protease Pathways in the Gastrointestinal TractR01DK081376 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2009 to 2010
$675k
NEW FUNCTION SERPIN PAI 2 AS A REGULAR OF RBR56CA098369 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI ANTALIS, TONI M · 2009 to 2009
$316k
CIHRNCI NIH HHS CA098369NCI NIH HHS P30 CA134274NCI NIH HHS R01 CA098369NCI NIH HHS R56 CA098369NHLBI NIH HHS HL084387NHLBI NIH HHS R01 HL084387NHLBI NIH HHS R01 HL118390NIDDK NIH HHS R01 DK081376
6 · The paper itself

Abstract

The type II transmembrane serine protease matriptase is a key regulator of epithelial barriers in skin and intestine. In skin, matriptase acts upstream of the glycosylphosphatidylinositol-anchored serine protease, prostasin, to activate the prostasin zymogen and initiate a proteolytic cascade that is required for stratum corneum barrier functionality. Here, we have investigated the relationship between prostasin and matriptase in intestinal epithelial barrier function. We find that similar to skin, matriptase and prostasin are components of a common intestinal epithelial barrier-forming pathway. Depletion of prostasin by siRNA silencing in Caco-2 intestinal epithelium inhibits barrier development similar to loss of matriptase, and the addition of recombinant prostasin to the basal side of polarized Caco-2 epithelium stimulates barrier forming changes similar to the addition of recombinant matriptase. However, in contrast to the proteolytic cascade in skin, prostasin functions upstream of matriptase to activate the endogenous matriptase zymogen. Prostasin is unable to proteolytically activate the matriptase zymogen directly but induces matriptase activation indirectly. Prostasin requires expression of endogenous matriptase to stimulate barrier formation since matriptase depletion by siRNA silencing abrogates prostasin barrier-forming activity. Active recombinant matriptase, however, does not require the expression of endogenous prostasin for barrier-forming activity. Together, these data show that matriptase and not prostasin is the primary effector protease of tight junction assembly in simple columnar epithelia and further highlight a spatial and tissue-specific aspect of cell surface proteolytic cascades.

Indexed as

Caco-2 CellsEnzyme ActivationEnzyme PrecursorsEpithelial CellsGene Expression Regulation, EnzymologicGene SilencingHumansIntestinal MucosaProstasinProteolysisSerine EndopeptidasesTight JunctionsEnzyme PrecursorsProstasinSerine EndopeptidasesST14 protein, human

Identifiers

PMID23443662
PMCPMC3624416
OpenAlexW1967822167

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.